Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
292.15
-1.85
(-0.63%)
As of 8:05:17 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
11,490,000
11,490,000
8,471,000
9,721,000
9,261,000
Investing Cash Flow
-1,046,000
-1,046,000
-26,204,000
-6,044,000
733,000
Financing Cash Flow
-9,415,000
-9,415,000
21,048,000
-4,037,000
-8,271,000
End Cash Position
11,973,000
11,973,000
10,944,000
7,629,000
7,989,000
Capital Expenditure
-1,096,000
-1,096,000
-1,112,000
-936,000
-880,000
Issuance of Debt
--
--
27,777,000
6,919,000
4,945,000
Repayment of Debt
-3,600,000
-3,600,000
-1,454,000
--
-4,150,000
Repurchase of Capital Stock
-200,000
-200,000
--
-6,360,000
-4,975,000
Free Cash Flow
10,394,000
10,394,000
7,359,000
8,785,000
8,381,000
12/31/2021 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AZN.L AstraZeneca PLC
12,062.00
-0.02%
GRFS Grifols, S.A.
8.71
+5.32%
SAN.PA Sanofi
108.80
-0.46%
ROG.SW Roche Holding AG
303.20
-0.33%
BAYN.DE Bayer Aktiengesellschaft
24.49
+4.12%
AZN AstraZeneca PLC
77.96
+0.92%
NVO Novo Nordisk A/S
90.86
+3.84%
MRK Merck & Co., Inc.
93.19
+0.68%
GILD Gilead Sciences, Inc.
115.44
+0.61%
LLY Eli Lilly and Company
929.72
+2.05%